<DOC>
	<DOCNO>NCT00083928</DOCNO>
	<brief_summary>The purpose study determine whether injection Å6 effective treating ovarian cancer patient complete first-line therapy currently detectable cancer experience double CA 125 level .</brief_summary>
	<brief_title>Efficacy Å6 Ovarian Cancer Patients Following First-Line Chemotherapy Rising CA125 Levels</brief_title>
	<detailed_description />
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<criteria>Females ≥18 year age Histologically cytologically document primary epithelial ovarian carcinoma , cancer Fallopian tube , primary peritoneal carcinoma Completion firstline chemotherapy Clinical remission result chemotherapy History normal CA125 level initial course therapy CA125 serum level show 2 consecutive rise base 3 consecutive sample mutually &gt; = 28 day apart , provide : 1. 3rd sample institution 's ULN , 2. 3rd sample confirm 4th sample likewise high 2nd sample value institution 's ULN No clinically evident disease progression , assessed history , physical examination , compute tomographic ( CT ) scan , magnetic resonance imaging ( MRI ) ECOG Performance Status 0 1 No clinically significantly abnormal clinical laboratory test concomitant illness Ability willingness selfadminister subcutaneous injection Although pregnancy extremely unlikely patient population disease prior treatment , patient potential become pregnant must negative pregnancy test must agree practice effective method contraception throughout trial . Persistent adverse event due agent administer 4 week earlier More 1 course previous chemotherapy qualify cancer Disease require chemotherapy radiotherapy Ascites Recent history active infection , gastrointestinal bleeding , thromboembolic disorder , anticoagulation</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Asymptomatic</keyword>
	<keyword>subcutaneous</keyword>
	<keyword>CA125 Progression</keyword>
	<keyword>Angstrom</keyword>
	<keyword>Ångstrom</keyword>
	<keyword>ovarian cancer</keyword>
</DOC>